Works by Sadeghi, Alireza

Results: 203
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Serum Profiles of Cytokines in Behcet's Disease.

    Published in:
    Journal of Clinical Medicine, 2017, v. 6, n. 5, p. 49, doi. 10.3390/jcm6050049
    By:
    • Sadeghi, Alireza;
    • Davatchi, Fereydoun;
    • Shahram, Farhad;
    • Karimimoghadam, Arezoo;
    • Alikhani, Majid;
    • Pezeshgi, Aiyoub;
    • Mazloomzadeh, Saeideh;
    • Sadeghi-Abdollahi, Bahar;
    • Asadi-Khiavi, Masoud
    Publication type:
    Article
    13
    14

    Associations between dietary patterns and the incidence of cardiovascular events in women with breast cancer: A cohort study.

    Published in:
    Nursing & Midwifery Studies, 2025, v. 14, n. 1, p. 21, doi. 10.48307/nms.2024.468588.1452
    By:
    • Vafaei, Zamaneh;
    • Maracy, Mohammad Reza;
    • Shekarchizadeh, Masood;
    • Najafan, Jamshid;
    • Mohammadifard, Noushin;
    • Chermahini, Siavash Hosseinpour;
    • Mostafavi, Samaneh;
    • Zavar, Reihaneh;
    • Darakhshandeh, Ali;
    • Khosravifarsani, Mohammadreza;
    • Ashrafi, Farzaneh;
    • Sharifi, Mehran;
    • Akhavan, Ali;
    • Mokarian, Fariborz;
    • Najafizadeh, Nadia;
    • Sadeghi, Alireza;
    • Mirporian, Maryam;
    • Sadeghi, Masoumeh;
    • Noori, Fatemeh;
    • Sarrafzadegan, Nizal
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Acute Massive Pulmonary Embolism.

    Published in:
    Texas Heart Institute Journal, 2005, v. 32, n. 3, p. 430
    By:
    • Sadeghi, Alireza;
    • Brevetti, Gregory R.;
    • Sanghyun Kim;
    • Burack, Joshua H.;
    • Genovese, Mark H.;
    • Distant, Dale A.;
    • Kodavatiganti, Ramesh;
    • Lowery, Robert C.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    A new anti-malarial drug against murine malaria.

    Published in:
    2011
    By:
    • Zamani, Zahra;
    • Tafreshi, Alireza Sadeghi;
    • Nahrevanian, Hossein;
    • Arjmand, Mohammad;
    • Lame-Rad, Behzad;
    • Sadeghi, Sedigheh;
    • Mirkhani, Fatemeh;
    • Eslamifar, Ali;
    • Pourfallah, Fatemeh;
    • Iravani, Ayda;
    • Wahabi, Farideh
    Publication type:
    Abstract
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.

    Published in:
    BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09895-5
    By:
    • Allahyari, Abolghasem;
    • Ehsanpour, Ali;
    • Najafi, Behrouz;
    • Ansarinejad, Nafiseh;
    • Mehrzad, Valiollah;
    • Kalantari, Behjat;
    • Raafat, Jahangir;
    • Ghadiany, Mojtaba;
    • Shahi, Farhad;
    • Gharib, Behrooz;
    • Moazed, Vahid;
    • Khosravi, Adnan;
    • Mirpour, Mir Hossein;
    • Salari, Sina;
    • Mortazavizadeh, Seyedmohammadreza;
    • Nekoyi, Amirabbas;
    • Khani, Mohsen;
    • Sadeghi, Alireza;
    • Gharib, Sirus;
    • Bary, Alireza
    Publication type:
    Article
    49

    Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.

    Published in:
    2022
    By:
    • Allahyari, Abolghasem;
    • Ehsanpour, Ali;
    • Najafi, Behrouz;
    • Ansarinejad, Nafseh;
    • Mehrzad, Valiollah;
    • Kalantari, Behjat;
    • Raafat, Jahangir;
    • Ghadiany, Mojtaba;
    • Shahi, Farhad;
    • Gharib, Behrooz;
    • Moazed, Vahid;
    • Khosravi, Adnan;
    • Mirpour, Mir Hossein;
    • Salari, Sina;
    • Mortazavizadeh, Seyedmohammadreza;
    • Nekoyi, Amirabbas;
    • Khani, Mohsen;
    • Sadeghi, Alireza;
    • Gharib, Sirus;
    • Bary, Alireza
    Publication type:
    Correction Notice
    50